Sagimet Biosciences, Inc. (SGMT)
5.96
-0.10
(-1.65%)
USD |
NASDAQ |
Dec 26, 16:00
5.95
-0.01
(-0.17%)
After-Hours: 20:00
Sagimet Biosciences EPS Diluted (Quarterly): -0.3976 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| HCA Healthcare, Inc. | 6.956 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.91M |
| Total Expenses (Quarterly) | 12.91M |
| Enterprise Value | 75.31M |
| Earnings Yield | -30.00% |
| Normalized Earnings Yield | -30.00 |